Stockscreener 앱 받기
17.95
4.88%
-0.92
시간 외 거래:
18.26
0.31
+1.73%
Urogen Pharma Ltd 주식(URGN)의 최신 뉴스
Goldman Sachs Group Inc. Sells 33,188 Shares of Urogen Pharma $URGN - MarketBeat
IPO Launch: What is UroGen Pharma Ltds 5 year growth outlook2025 Analyst Calls & Risk Managed Investment Entry Signals - khodrobank.com
Urogen Pharma (NASDAQ:URGN) Rating Increased to Hold at Wall Street Zen - MarketBeat
Aug Sectors: How cyclical is UroGen Pharma Ltd.’s revenue stream2025 Historical Comparison & High Return Stock Watch Alerts - khodrobank.com
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Boosts Position in Urogen Pharma $URGN - MarketBeat
Is it too late to sell UroGen Pharma Ltd.Market Performance Report & Free Fast Entry Momentum Trade Alerts - newser.com
Aug Breakouts: What is Piedmont Office Realty Trust Inc. s revenue forecastMarket Activity Report & Capital Protection Trade Alerts - khodrobank.com
Buybacks Report: Will UroGen Pharma Ltd benefit from rate cutsGold Moves & Daily Volume Surge Trade Alerts - خودرو بانک
Surprises Report: Is UroGen Pharma Ltd. benefiting from innovation trendsQuarterly Growth Report & Expert-Curated Trade Recommendations - khodrobank.com
Urogen Pharma $URGN Shares Sold by Trexquant Investment LP - MarketBeat
Investment Recap: Will UroGen Pharma Ltd. benefit from rising consumer demand2025 Geopolitical Influence & Fast Momentum Entry Tips - khodrobank.com
Smart Money: Can UroGen Pharma Ltd ride the EV wave2025 Analyst Calls & Verified Trade Idea Suggestions - khodrobank.com
Urogen Pharma (NASDAQ:URGN) Shares Down 8% Following Insider Selling - MarketBeat
Big Money Moves: Will UroGen Pharma Ltd benefit from rate cutsJuly 2025 Chart Watch & Reliable Breakout Forecasts - khodrobank.com
Volume Summary: What analysts say about UroGen Pharma Ltd stock2025 Geopolitical Influence & AI Powered Trade Plan Recommendations - khodrobank.com
Earnings Miss: What analysts say about UroGen Pharma Ltd stock2025 Sector Review & Fast Moving Trade Plans - خودرو بانک
Treasury Yields: Is UroGen Pharma Ltd a cyclical or defensive stock2025 Bull vs Bear & Low Risk High Reward Trade Ideas - khodrobank.com
Aug Shorts: Will UroGen Pharma Ltd face regulatory challenges2025 Winners & Losers & Safe Entry Zone Tips - khodrobank.com
Aug Action: How cyclical is UroGen Pharma Ltd.’s revenue stream2025 Technical Patterns & Expert Verified Movement Alerts - khodrobank.com
What machine learning models say about UroGen Pharma Ltd.2025 Price Momentum & Verified Swing Trading Watchlists - newser.com
Stop Loss: What are the risks of holding UroGen Pharma LtdWeekly Gains Report & Weekly Watchlist of Top Performers - خودرو بانک
Breakout Watch: Can UroGen Pharma Ltd. stock outperform in a bear marketEarnings Performance Report & Technical Pattern Based Signals - خودرو بانک
US Market Wrap: Can UroGen Pharma Ltd. disrupt its industryStock Surge & Stepwise Entry/Exit Trade Alerts - khodrobank.com
Trend analysis for UroGen Pharma Ltd. this weekWeekly Trend Recap & Technical Pattern Based Signals - newser.com
Urogen Pharma (NASDAQ:URGN) General Counsel Jason Drew Smith Sells 1,520 Shares - MarketBeat
Urogen Pharma (NASDAQ:URGN) Shares Up 10.6%Time to Buy? - MarketBeat
Urogen Pharma (NASDAQ:URGN) Hits New 1-Year HighHere's Why - MarketBeat
Urogen Pharma (NASDAQ:URGN) Raised to Hold at Wall Street Zen - Defense World
Parkman Healthcare Partners LLC Has $4.35 Million Holdings in Urogen Pharma $URGN - MarketBeat
Adage Capital Partners GP L.L.C. Sells 1,651,086 Shares of Urogen Pharma $URGN - MarketBeat
Brokerages Set Urogen Pharma (NASDAQ:URGN) PT at $32.00 - MarketBeat
Urogen Pharma (NASDAQ:URGN) Insider Mark Schoenberg Sells 871 Shares - MarketBeat
UroGen Pharma’s chief medical officer Schoenberg sells $16k in shares - Investing.com India
Urogen Pharma (URGN) general counsel sells $29k in shares - Investing.com India
Urogen Pharma (URGN) general counsel sells $29k in shares By Investing.com - Investing.com Nigeria
Breakeven On The Horizon For UroGen Pharma Ltd. (NASDAQ:URGN) - simplywall.st
UroGen Pharma at H.C. Wainwright Conference: Zosduri’s Market Impact By Investing.com - Investing.com Australia
UroGen Pharma at H.C. Wainwright Conference: Zosduri’s Market Impact - Investing.com
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
UroGen Pharma (URGN) Awards Restricted Stock Units to New Employ - GuruFocus
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing R - GuruFocus
Urogen Pharma announces inducement grants under Nasdaq Listing Rule - MarketScreener
67,700 Shares: UroGen Pharma Expands Team with 40 New Hires to Drive Cancer Treatment Portfolio Growth - Stock Titan
1.43%
0.09%
자본화:
|
볼륨(24시간):